Philips and Catharina Hospital Collaborate to Highlight Innovation in Heart Rhythm Disorder Treatment

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHI) and the Catharina Hospital in the Netherlands, a leading interventional cardiology center, have teamed up to showcase current solutions and future developments that shape the diagnosis and minimally invasive treatment of heart rhythm disorders.

The Catharina Hospital, Philips and other partners are today hosting a symposium in Eindhoven titled Evolution in Healthcare, which will feature presentations from leading experts in the healthcare industry to illustrate the crucial role of innovation in the evolution of healthcare. At the symposium, innovations in heart rhythm disorder treatment will be discussed as an example of how technological innovation can improve the life of patients and benefit society.

In late 2011, Philips and Catharina Hospital worked together on building a state-of-the-art electrophysiology (EP) lab for the treatment of heart rhythm disorders. This partnership was followed by a unique social media initiative in the Netherlands focused on Dutch heart patient Ad Langendonk. Starting on January 10, Mr. Langendonk and his cardiologist, Dr Lukas Dekker, used Twitter before, during and after a minimally-invasive intervention during which catheters were used to remedy Mr. Langendonk's heart rhythm disorder. The intervention was successfully performed on January 27, allowing Mr. Langendonk to begin the process of regaining his quality of life.

"The challenge in healthcare is to improve the quality of care while at the same time satisfying increased demand and controlling costs," says Dr Lukas Dekker, cardiologist at the Catharina Hospital in Eindhoven. "Innovation is the only means by which we can arrive at sustainable solutions. We need to keep investing in innovation and to that end it is important to increase public awareness of what we are doing. That is why I am so enthusiastic about these initiatives. In this way, people are brought together, ideas are exchanged, be it in person or via the Internet."

"Innovation is an important piece of the healthcare puzzle," says Hans Bossink, General Manager Philips Healthcare Benelux. "Ultimately, healthcare is all about people - the patient and the care provider. We wanted to provide a platform that enables people to experience what innovation means for medical procedures and the impact it has on the delivery of care as well as the clinical outcome."

Heart rhythm disorders are caused by disturbed electrical signals that regulate the heart beat and can lead to serious health risks, including heart failure or stroke. Many heart rhythm disorders, including atrial fibrillation (AF), can be treated using minimally invasive electrophysiology (EP) procedures, carried out in an EP lab. These procedures require advanced image guidance and interventional tools that enable physicians to achieve the optimum clinical outcome, while minimizing adverse events.

In the new EP Lab in the Catharina Hospital, integration of real-time information from various relevant technologies has been realized. Harnessing vital procedural and imaging information from sources such as electrograms, 3D mapping and imaging systems, the lab provides EP team members with the information they need in order to be confident in their decision making. For efficient workflow, the information is presented on one large display that can be controlled from the same keyboard and mouse.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified health and well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 122,000 employees with sales and services in more than 100 countries worldwide. With sales of EUR 22.6 billion in 2011, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in male shaving and grooming, portable entertainment and oral healthcare.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...